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A biotransformação da lignana tetraidrofurânica, (-)-grandisina, pelo fungo endofítico 
Phomopsis sp, obtido de Viguiera arenaria, conduziu à formação de um novo metabólito 
caracterizado como 3,4-dimetil-2-(4’-hidróxi-3’,5’-dimetóxifenil)-5-metóxi-tetraidrofurano. 
O metabólito foi analisado contra o parasita Trypanosoma cruzi, o agente causador da doença 
de Chagas, e mostrou uma atividade tripanocida (IC50 9,8 µmol L-1) similar ao precursor natural  
(IC50 3,7 µmol L-1). 
The biotrasformation of the tetrahydrofuran lignan, (-)-grandisin, by the endophitic fungus 
Phomopsis sp, obtained from Viguiera arenaria, led to the formation of a new compound 
determined as 3,4-dimethyl-2-(4’-hydroxy-3’,5’-dimethoxyphenyl)-5-methoxy-tetrahydrofuran. 
The metabolite was evaluated against the parasite Trypanosoma cruzi, the causative agent of 
Chagas’s disease, and showed a trypanocidal activity (IC50 9.8 µmol L-1) similar to the natural 
precursor (IC50 3.7 µmol L-1). 
Keywords: biotransformation, 2,5-diaryltetrahydrofuran, endophytic fungus, (-)-grandisin, 
trypanocidal activity
Introduction
The lignan family is a large group of natural products 
with noteworthy therapeutic activity as illustrated by 
podophyllotoxin derivatives (e. g. etoposide) with antitumoral 
activity.1 In particular, the optically active tetrahydrofuran 
lignans display a wide range of pharmacological activities, 
including anti-parasite,2-4 antibacterial,5 antifungal,6 anti-
tumoral,7 anti-inflammatory8,9 and platelet-activating factor 
(PAF) inhibition.10-12 
Several non-symmetrical 2,5-diaryltetrahydrofuran 
lignans, shown in Table 1, have been isolated from 
Piper species (Piperaceae) containing either piperonyl, 
veratryl or 3,4,5-trimethoxyphenyl substituent at 2 and 5 
positions and methyl groups at 3 and 4 positions attached 
to the tetrahydrofuran ring, as illustrated by (+)-calopiptin 
(1, P. schmidtii), 5-[rel-(2S,3S,4S,5S)-5’-(3’’,4’’-
dimethoxyphenyl)-3’,4’-dimethyl-2’-tetrahydro-furanyl)]-
1,3-benzodioxole (2, P. wightii), (2S,3R,4S,5R)-3,4-
dimethyl-2,5-bis(3’,4’-dimethoxyphenyl)-tetrahydrofuran 
(3, P. clarkii), (±)-galgravin (4, P. futokadsura, P. hancei, 
P. puberculum, P.wallichii), (-)-galbelgin (5, P. attenuatum, 
P. futokadsura, P. thomsoni, P. wightii), (+)-grandisin 
(6, P. polysyphorum), (+)-machilin G (7, P. schmidtii, P. 
wightii), (+)-veraguensin (8, P. cuneifolium, P. futokadsura, 
P. puberculum) and (-)-zuonin A (9, P. schmidtii).13 Other 
bis-tetrahydrofuran lignans have also been described from 
Achillea lingulata (Asteraceae).14
In previous reports, Martins et al.3 described the isolation 
of (-)-grandisin (6) from Piper solmsianum and Lopes and 
co-workers 4,15 from Virola surinamensis (Rol.) Warb, which 
belong to Piperaceae and Myristicaceae, respectively. The 
tetrahydrofuran lignan (-)-grandisin (6) showed a potent 
trypanocidal activity against the trypomastigote form of 
Trypanosoma cruzi, responsible for Chagas´s disease in 
Latin America, at 5 µg mL-1 leading to a total parasite 
lysis after 24 h, without hematiae damage.4 Furthermore, 
veraguensin (8) also isolated from Virola surinamensis4 
preserved this anti-parasite pattern along with a potent 
platelet-activating factor (PAF) inhibitory activity that may 
be involved in the mechanisms of the parasite growing 
and differentiation.16 Nevertheless, attempts to overcome 
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the poor water solubility of compounds 6 and 8 for in vivo 
evaluation, comprising semi-synthetic modifications such 
as O-demethylation of the methoxy groups attached to the 
aromatic rings, led to byproducts due to the presence of 
two benzylic carbons in the tetrahydrofuran ring that were 
very unstable under acidic or base conditions.17
The biotransformation of the naturally occurring 
2,5-diaryl-3,4-dimethyltetrahydrofurans with PAF inhibitory 
activity, such as (+)-veraguensin (8), (+)-galbelgin (3) 
and galgravin (4) named as 7,7’-epoxylignans, has been 
investigated in order to obtain novel and bioactive derivatives. 
In the series, carrying a 3,4-dimethoxyphenyl substituents 
pattern, both methyl groups at para-position of the aromatic 
rings were metabolized and cleaved by Aspergillus niger 
yielding the corresponding 4,4’-O-demethyl derivatives.18 
Similar results were also achieved using furofuran lignans 
with the 2,6-diaryl-3,7-dioxabicyclo[3.3.0]octane skeleton,19 
such as (+)-magnolin and (+)-eudesmin. Replacing the 
3,4-dimethoxyphenyl groups by 3,4,5-trimethoxyphenyl 
(e. g. (+)-yangabin) and 4,5-dihydroxy-3-methoxyphenyl 
groups on the lignans lead to a stable para-methoxy groups 
not cleaved by A. niger. On the other hand, the use of 
larvae of Spodoptera litura20 or rats as a source of liver 
metabolized enzymes21,22 allowed the O-demethylation 
at the para-position of both aromatic rings of furofuran 
lignans containing either di- or trimethoxyphenyl groups, 
being the pre-formed hydroxyl group frequently conjugated 
to glycosides. The grandisin (6) has also been di-O-
demethylated by Lepidopterae and Coleoptera species.23
The biotransformation reactions of lignans, including 
podophyllotoxin, and neolignans was described in a recent 
review.24 
Endophytic fungi are prolific producers of natural 
products, since they live inside the health plant tissues 
without causing any apparent disease.25 These environmental 
conditions might stimulate the fungi to produce a range of 
metabolic enzymes as a requirement for their survival 
in the presence of toxic defense compounds of plants.26 
Endophytes have also been successfully used in the 
biotransformation of natural products.27,28 
These findings stimulated us to investigate about 
20 endophytic strains from our collection of fungi29 as 
biocatalyst systems and effective method for regio- and 
stereoselective production of novel and bioactive products. 
This procedure could convert unreactive methoxy groups 
to hydroxyl functions of a tetrahydrofuran lignan under 
mild conditions which may increase the solubility of 6. 
Thus, this study focuses on the biotransformation of 6 
by four different endophytic fungi with the aim to obtain 
potential trypanocidal derivatives with improved drug-like 
properties. 
Experimental
General procedures
GC-MS were measure at 70 eV on a Shimadzu Model: 
QP2010, 120 ºC (oven temp.), using a DB-5MS (30 m × 
Table 1. Non-symmetrical 2,5-diaryltetrahydrofuran lignans isolated from Piper species 
Compound R2 R2’ R3 R3’ R4 R4’ R5 R5’
1 piperonyl H H CH3 CH3 H veratryl H
2 veratryl H H CH3 CH3 H H piperonyl
3 veratryl H CH3 H CH3 H veratryl H
4 veratryl H CH3 H CH3 H H veratryl
5 H veratryl CH3 H H CH3 veratryl H
6 3’,4’,5’-trime 
thoxyphenyl
H H CH3 CH3 H H 3’,4’,5’-trime 
thoxyphenyl
7 piperonyl H H CH3 H CH3 veratryl H
8 veratryl H H CH3 CH3 H veratryl H
9 piperonyl H CH3 H CH3 H H Piperonyl
Modified since were included higher number of examples with tetrahydrofuran skeleton in relation of the  original.13
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0.25 mm × 0.25 µm). ESI analysis were performed on a 
ultrOTOFQ-ESI-TOF MS (End Plate: 4000 Volts, Capillary: 
4500 Volts, Capillary Exit: 300 Volts, Skimmer 1: 50 Volts, 
Skimmer 2: 25 Volts, Transfer: 90 µs, Collision Exit Gate: 
80 µs).1H NMR spectrum was measured on a Bruker DPX-
400 (400 MHz) while 2D experiments (HSQC and HMBC) 
were recorded in a Bruker DRX-400 (400 and 100 MHz) 
using CDCl3 (Aldrich) as solvent and TMS as int. standard. 
Chemical shifts were reported in  units (ppm) and coupling 
constants (J) in Hz. TLC: silica gel 60 F254 pre-coated (layer 
thickness 0.25 mm, Merck); CC: silica gel with hexane-
EtOAc 4:6, v/v. The instrumentations for HPLC analysis 
consisted of a Shimadzu (SCL-10Avp, Japan) multisolvent 
delivery system, Shimadzu SCL-M10vp Photodiode Array 
detector, and an Intel Celeron computer for analytical 
system control and data collection. Chromatography was 
carried out using the isocratic method with methanol:water 
7/3, v/v within 20 minutes during the screening phase 
for the evaluation of grandisin biotransformation 
(condition A). The mobile phase used during the isolation 
of the metabolites was methanol:water 6:4, v/v within 
60 minutes (condition B). A CLC-ODS (M)- 4.6 × 250 mm 
Shimadzu column was used at a flow of 1.0  mL min-1. 
The spectral data from the detector were collected over de 
200-400 nm range of absorption chromatograms, and the 
chromatograms were plotted at 225 nm.
Grandisin was obtained from dichloromethane extracts 
from twigs of Virola surinamensis, which yielded two 
steroids, two lignans (compounds 6 and 8), five flavonoids 
and one polyketide.4
Microorganisms and culture
The endophytic fungi have been isolated and identified 
by their rDNA sequences as previously described.29 The 
strains are maintained on PDA slants at 4 ºC. Initially the 
fungi were screened for their ability to transform grandisin. 
Fungi were cultivated on PDA in Petri dish for 7 days at 
30 ºC and agar pieces (1 cm2) containing fungal mycelia 
was used as inocullum. Strain SS42 was also identified by 
“Micoteca URM/ Depto. de Microbiologia/ CCB/ UFPE” 
(Av. Prof. Nelson Chaves, s/n, 50670-420 Recife-PE, 
Brazil). 
A two-step culture was used for each fungus. Initially, 
the fungi were inoculated into 20 mL of Czapek medium, 
supplemented with 3% of sucrose and the cultures were 
incubated at 30 ºC for 3 days, with shaking at 120 ºC rpm. 
After cultivation the resulting mycelia were harvested by 
filtration and transferred to 20 mL of Czapek medium, 
containing 1% of sucrose and supplemented with a solution 
of grandisin in DMSO, resulting 0.4 mg mL-1 as final 
concentration in the media. The cultures were reincubated 
at the same conditions for 8 days.
Extraction of the metabolites 
The culture broths were separated from mycelia by 
vacuum filtration, followed by 3 times partition sequentially 
with ethyl ether, ethyl acetate and n-butanol (10 mL). The 
solvents were evaporated and the crude extracts were 
analyzed by TLC and HPLC (condition A). 
Isolation of the metabolites 
After the preliminary screening, Phomopsis sp (VA35) 
culture was scaled up to 150 mL using the same conditions 
already described, including the proportion of grandisin (6) 
(60 mg), but changing the fermentation time to 9 days. The 
ethyl ether and ethyl acetate extracts were joined because 
they showed similar profiles. The crude extract obtained 
was purified by Silica-gel column chromatography using 
hexane/ethyl acetate 1:1, yielding 4 fractions. Fraction 3 
was further purified through HPLC (Condition B) to yield 
compound 10 (1.0 mg).
In vitro trypanocidal assay 
The bioassays were carried out using the blood of 
infected Swiss albino mice, collected by cardiac puncture 
on the parasitemy peak (7th day) after infection with Y 
strains of T. cruzi. The infected blood was diluted with 
the blood health mice to achieve a concentration of 106 
trypomastigote per mL. The assays were performed on 
titration microplates (96 wells) in duplicate. The compound 
10 was dissolved in dimethyl sulfoxide (DMSO) and was 
added into the infected mouse to provide concentration of 
0.5, 2.0, 8 and 32 µmol L-1. The plates were incubated at 
4 ºC and the numbers of parasites were counted after 24 h. 
Negative and positive controls containing either DMSO 
or crystal violet at 250 µg mL-1, respectively were run in 
parallel.30
Results and Discussion
The microbial transformations of (-)-grandisin (6) 
by endophytic fungi were investigated in a small scale 
screening test (8 mg) monitored by TLC and HPLC analyses 
(condition A). Among the 20 endophytic fungi, Curvularia 
lunata (SS-42), isolated from Smallanthus sonchifolius, 
and Phomopsis sp. (VA-35), obtained from Viguiera 
arenaria, showed better results in the biotransformation 
of 6. Phomopsis sp. was selected to be cultivated in large 
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scale experiments because of its great ability to generate 
metabolites in the preliminary tests. 
The metabolization of compound 6 (60 mg), with a 
retention time of 40.23 min as indicated by HPLC analysis 
(condition B), led to the generation of a major metabolite (10) 
with a distinct retention time of 10.35 min. Compound 10 
was purified by column chromatography, followed by HPLC 
(condition B). Condition B was established by exploring its 
different interaction properties with the reverse phase column 
(C-18), in a manner similar to that previously reported for 
butyrolactones isolated from Virola surinamensis.31,32
GC-MS analysis showed that compound 10 has a 
molecular weight lower than grandisin with a [M]+. at 
m/z 282 and fragments (m/z 68, 85, 100, 167 and 182) 
suggesting the molecular formula C15H22O5. In fact, the 
High Resolution Mass Spectrometry confirms the proposed 
molecular formula with a detectable [M + Na]+ 305.1368 
and a corresponding theoretic mass of 305.1365. 
The structure of compound 10 was established by 1D 
and 2D NMR data. For instance, the 1H NMR spectrum 
of compound 10 showed two methoxy proton signals at d 
3.37 and 3.83 with a relative integration of 3:6, which were 
characteristic of groups attached to aliphatic and aromatic 
skeleton, respectively. Moreover, the ortho-aromatic proton 
signals were assigned at d 6.52 (s, 2H), while the methyl 
groups at C-13 and C-12 were observed at d 1.10 and d 0.87 
as two doublets (J 6.9 Hz). 
Nearly all relevant spectral details of the isolated 
metabolites were closely comparable to the corresponding 
13C and 1H features of grandisin,4,33 but no data for the second 
aromatic ring were observed by the integration of signals. In 
addition, a hemiacetal proton was observed at d 4.71 (d, 1H), 
attached to a carbon at d 111.1 as observed in the HMQC 
experiment. Also, the signal at d 3.83 was assigned to the 
methoxy groups at meta positions of the remaining aromatic 
ring linked to the tetrahydrofuran nucleus, indicating the 
presence of a free hydroxyl group at para position. Methoxy 
aliphatic protons at d 3.37 and methyl protons at d 1.10 
showed correlation in the HMBC with carbon at d 111.1, 
unequivocally establishing the methoxy group at C-5. These 
data confirmed the presence of a single aromatic ring in 
compound 10, and an extra methoxy group at C-5. The main 
HMBC correlations for compound 10 are shown in Figure 
1 and data described in Table 2. 
Thus, from the foregoing spectral data the structure 
of compound 10 was characterized as 3,4-dimethyl-
2-(4’-hydroxy-3’,5’-dimethoxyphenyl)-5-methoxy-
tetrahydrofuran. To our knowledge, this compound has not 
been previously described in the literature.
We propose that the peculiar aliphatic methoxy 
groups of compound 10 should be generated firstly by a 
microbial oxidative metabolism at position C-5 followed 
by rearrangement to a lactone displacing the aromatic 
ring. Further reduction to the hemiketal function and 
O-methylation of the nearly formed hydroxyl group 
might explain how the fungus converted the 3,4,5 
trimethoxyphenyl group of compound 6 to methoxy group 
of the metabolite 10. 
The HPLC separation (condition B) provided a second 
metabolite with a retention time of 12.50 min. GC-MS 
analysis showed that this compound has the same molecular 
weight and fragments presented by compound 10. The 
High Resolution Mass Spectrometry detected [M + Na]+ 
305.1368. 1H NMR spectrum revealed the same integrals, 
but insufficient data could be obtained from 2D analysis 
because of the small isolated quantity. 
The results from 1H NMR spectrum, GC-MS and high 
resolution mass spectrometry suggested that this secondary 
compound might be an epimer of compound 10.
Figure 1. Selected HMBC correlations for metabolite 10 obtained in the 
biotrasformation process.
Table 2. 1HMR (400 MHz) and 13C (100 MHz) data for compound 10 
(CDCl3)
Position Conpound 10
dH dC
2 4.36 (d, J 9.6, 1H) 86.7
3, 4 1.78 (m, 2H) 45.8
5 4.71 (d, J 4.7, 1H) 111.1
6 ---- 130.8
7, 11 6.52 (s, 2H) 103.2
8, 10 ---- 143.6
9 ---- 143.2
12 0.87 (d, J 6.9, 3H) 14.0
13 1.10 (d, J 6.9, 3H) 15.7
OH 5.41 (s, 1H) ----
OMe 3.37 (s, 3H) 56.1
OMe 3.83 (s, 6H) 55.6
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The percentage of lyses observed for the trypomastigote 
form of T. cruzi treated with compound 10, as outlined in 
Figure 2, was similar to the corresponding natural product 
6.4 Based on experiments involving the Y strains of T. cruzi 
compounds 6 and 8 were able to cause lyses of parasites 
with IC50 3.7 and 2.3 µmol L-1 respectively,33,34 while the 
biotransformation product 10 displayed IC50 9.8 µmol L-1. 
Conclusions
The product 3,4-dimethyl-2-(4’-hydroxy-3’,5’-
dimethoxyphenyl)-5-methoxy-tetrahydrofuran (10) was 
successfully obtained from the biotransformation of 
grandisin (6) by the endophytic fungus Phomopsis sp. 
The evaluation of the trypanocidal activity of compound 
10 and its corresponding natural precursor 6 gave similar 
results, revealing that a unique methoxylated aromatic ring 
bound to the central tetrahydrofuran scaffold might preserve 
the trypanocidal activity, this represents an interesting 
molecular simplification for synthetic purposes. 
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Figure S1. High resolution mass spectrometry of compound 10.
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Figure S2. 1H NMR of compound 10 (400 MHz, CDCl3).
Figure S3. HMQC of compound 10. (400 MHz, CDCl3).
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Figure S4. 1H NMR of compound 6 (grandisin) (400 MHz, CDCl3).
Figure S5. 13C  NMR of compound 6 (grandisin) (100 MHz, CDCl3).
